227 related articles for article (PubMed ID: 16537666)
1. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.
Parr DG; Stoel BC; Stolk J; Stockley RA
Thorax; 2006 Jun; 61(6):485-90. PubMed ID: 16537666
[TBL] [Abstract][Full Text] [Related]
2. Progression parameters for emphysema: a clinical investigation.
Stolk J; Putter H; Bakker EM; Shaker SB; Parr DG; Piitulainen E; Russi EW; Grebski E; Dirksen A; Stockley RA; Reiber JH; Stoel BC
Respir Med; 2007 Sep; 101(9):1924-30. PubMed ID: 17644366
[TBL] [Abstract][Full Text] [Related]
3. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
[TBL] [Abstract][Full Text] [Related]
4. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA
Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952
[TBL] [Abstract][Full Text] [Related]
5. Assessment of regional progression of pulmonary emphysema with CT densitometry.
Bakker ME; Putter H; Stolk J; Shaker SB; Piitulainen E; Russi EW; Stoel BC
Chest; 2008 Nov; 134(5):931-937. PubMed ID: 18625668
[TBL] [Abstract][Full Text] [Related]
6. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
[TBL] [Abstract][Full Text] [Related]
7. Repeatability of lung density measurements with low-dose computed tomography in subjects with alpha-1-antitrypsin deficiency-associated emphysema.
Stolk J; Dirksen A; van der Lugt AA; Hutsebaut J; Mathieu J; de Ree J; Reiber JH; Stoel BC
Invest Radiol; 2001 Nov; 36(11):648-51. PubMed ID: 11606842
[TBL] [Abstract][Full Text] [Related]
8. Influence of calibration on densitometric studies of emphysema progression using computed tomography.
Parr DG; Stoel BC; Stolk J; Nightingale PG; Stockley RA
Am J Respir Crit Care Med; 2004 Oct; 170(8):883-90. PubMed ID: 15271692
[TBL] [Abstract][Full Text] [Related]
9. Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.
Parr DG; Sevenoaks M; Deng C; Stoel BC; Stockley RA
Respir Res; 2008 Feb; 9(1):21. PubMed ID: 18271964
[TBL] [Abstract][Full Text] [Related]
10. Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency.
Stolk J; Ng WH; Bakker ME; Reiber JH; Rabe KF; Putter H; Stoel BC
Thorax; 2003 Dec; 58(12):1027-30. PubMed ID: 14645966
[TBL] [Abstract][Full Text] [Related]
11. Maximal mid-expiratory flow detects early lung disease in α
Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373
[TBL] [Abstract][Full Text] [Related]
12. Volume adjustment of lung density by computed tomography scans in patients with emphysema.
Shaker SB; Dirksen A; Laursen LC; Skovgaard LT; Holstein-Rathlou NH
Acta Radiol; 2004 Jul; 45(4):417-23. PubMed ID: 15323394
[TBL] [Abstract][Full Text] [Related]
13. Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency.
Holme J; Stockley RA
Chest; 2007 Sep; 132(3):909-15. PubMed ID: 17573491
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
[TBL] [Abstract][Full Text] [Related]
15. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.
Dirksen A; Piitulainen E; Parr DG; Deng C; Wencker M; Shaker SB; Stockley RA
Eur Respir J; 2009 Jun; 33(6):1345-53. PubMed ID: 19196813
[TBL] [Abstract][Full Text] [Related]
16. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
[TBL] [Abstract][Full Text] [Related]
17. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
18. Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema.
Shaker SB; Dirksen A; Laursen LC; Maltbaek N; Christensen L; Sander U; Seersholm N; Skovgaard LT; Nielsen L; Kok-Jensen A
Acta Radiol; 2004 Jul; 45(4):424-30. PubMed ID: 15323395
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline.
Dowson LJ; Guest PJ; Stockley RA
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1805-9. PubMed ID: 11734427
[TBL] [Abstract][Full Text] [Related]
20. Rate of progression of lung function impairment in alpha1-antitrypsin deficiency.
Dawkins PA; Dawkins CL; Wood AM; Nightingale PG; Stockley JA; Stockley RA
Eur Respir J; 2009 Jun; 33(6):1338-44. PubMed ID: 19164359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
